MCCULLOCH KEVIN (See Remarks) reported 1 transaction at XERIS BIOPHARMA HOLDINGS, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 8/4/2025ACC: 0001867096-25-000123
Officer· See Remarks
Since Mar 2026
-14.65K
Net shares
Net seller
$78.8K
Total sold
0
Open market trades
0B · 0S
1
Total transactions
14.65K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−14.65K
Price / share
$5.38
Trade value
$78.82K
% of position
0.9%
8/1/2025
1.72M→1.70M
Total
Net shares
−14.65K
Net value
-$78.82K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/1/2025 | F · Tax Withholding | −14.65K | $5.38 | $78.82K | 0.9% | 1.72M | 1.70M |
| Total | −14.65K | -$78.82K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)2
Common Stock
IndirectShares owned25K
Common Stock
IndirectShares owned2K
Total
27K indirect27K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 25K | Indirect |
| Common Stock | 2K | Indirect |
| Total | 27K | 27K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported